Sparfloxacin reveals a host–virus dual-target antiviral scaffold against respiratory syncytial virus
Open Access
- 8 August 2026
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Abstract
Respiratory syncytial virus (RSV) is a major cause of severe respiratory illness across the lifespan, particularly in infants and older adults. Nonetheless, effective antiviral therapies remain limited. Here, we performed a clinically guided, medium-throughput screening of approved drugs used in pediatric populations and identified sparfloxacin (SPFX), a fluoroquinolone antibiotic, as a mechanistically informative antiviral scaffold. SPFX showed antiviral activity against genetically distinct RSV clinical isolates in vitro, and suppressed RSV infection in a mechanistic mouse model in vivo. Mechanistically, our findings support a host–virus dual-target framework in which SPFX suppresses RSV replication through activity consistent with modulation of viral RNA polymerase function together with a pro-viral HSP70-associated host pathway. Using primary human pediatric airway epithelial cells, we identified SPFX-responsive host factors and observed suppression of HSP70 expression independent of infection. Together, these findings establish SPFX as a mechanistically informative antiviral scaffold and support a host–virus dual-target framework for future RSV therapeutic development.Keywords
This publication has 59 references indexed in Scilit:
- Structure of the Respiratory Syncytial Virus Polymerase ComplexCell, 2019
- Zika Virus Dependence on Host Hsp70 Provides a Protective Strategy against Infection and DiseaseCell Reports, 2019
- Identification of Compound-B, a novel anti-dengue virus agent targeting the non-structural protein 4AAntiviral Research, 2018
- Fluoroquinolone-Gyrase-DNA Cleaved Complexes2017
- Drug candidates and model systems in respiratory syncytial virus antiviral drug discoveryBiochemical Pharmacology, 2017
- Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistanceCurrent Opinion in Virology, 2014
- Recombinant respiratory syncytial virus F protein expression is hindered by inefficient nuclear export and mRNA processingVirus Genes, 2010
- Expression of tight junction proteins in epithelium including Ck20-positive M-like cells of human adenoids in vivo and in vitroJournal of Molecular Histology, 2008
- Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infectionsJournal of Medical Virology, 2006
- Physicochemical property of bovine brain 73-kDa stress proteinInternational Journal of Biochemistry, 1993